Utility of angiography-physiology coregistration maps during percutaneous coronary intervention in clinical practice.


Journal

Cardiovascular intervention and therapeutics
ISSN: 1868-4297
Titre abrégé: Cardiovasc Interv Ther
Pays: Japan
ID NLM: 101522043

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 03 02 2020
accepted: 16 04 2020
pubmed: 9 6 2020
medline: 29 6 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

This study aimed to evaluate the utility and feasibility of physiological maps coregistered with angiograms using the pullback of a pressure guidewire with continuous instantaneous wave-free ratio (iFR) measurements. iFR pullback was obtained for 70 lesions from 70 patients with stable angina pectoris using SyncVision (Philips Corp.). Physiological maps were created, whereby the post-intervention iFR (post-iFR) was predicted as iFRpred. The iFR gap was defined if the difference between the iFRpred and post-iFR was ≥ 0.3. The lesion morphology changed from that during the physiological assessment to that during the angiographic assessment in 26 lesions (37.1%). In particular, 22.6% of angiographic tandem lesions changed to physiological focal lesions. The mean pre-intervention iFR, post-iFR, and iFRpred were 0.73 ± 0.17, 0.90 ± 0.06, and 0.93 ± 0.05, respectively. The mean difference between the iFRpred and post-iFR was 0.029 ± 0.099, with 95% limits of agreement of -0.070-0.128. iFR gaps occurred in 28 patients (40%). Notably, a new iFR gradient causing a ≥ 0.03 iFR drop after stenting occurred in 11 (15.7%) cases. The study patients were divided into two groups according to biases between post-iFR and iFRpred < 0.03 (good concordance group) or ≥ 0.03 (poor concordance group). The pre-intervention heart rate was the only independent predictor of poor concordance (odds ratio, 0.936; 95% confidence interval 0.883-0.992; p = 0.027). Physiological maps under resting conditions may contribute to a reduction in unnecessary stent placements without missing lesions requiring treatment. However, the predictive accuracy of post-iFR performance in the present study was slightly lower than that in the previous reports.

Identifiants

pubmed: 32507942
doi: 10.1007/s12928-020-00668-0
pii: 10.1007/s12928-020-00668-0
pmc: PMC8019415
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-218

Références

Circulation. 2017 Nov 7;136(19):1798-1808
pubmed: 28851731
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241
pubmed: 28291663
Circulation. 1993 Jul;88(1):62-9
pubmed: 8319357
Am J Cardiol. 2012 Dec 1;110(11):1578-84
pubmed: 22921996
JACC Cardiovasc Interv. 2014 Dec;7(12):1386-96
pubmed: 25459526
Circulation. 2011 Dec 6;124(23):e574-651
pubmed: 22064601
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
Circ Res. 1981 Sep;49(3):584-93
pubmed: 7261259
J Cardiol. 2018 May;71(5):458-463
pubmed: 29203079
Int J Cardiol. 2014 Sep 20;176(2):399-404
pubmed: 25125008
N Engl J Med. 2017 May 11;376(19):1813-1823
pubmed: 28317438
JACC Cardiovasc Interv. 2018 Apr 23;11(8):757-767
pubmed: 29673507
Circulation. 1990 Apr;81(4):1319-30
pubmed: 2317912
J Am Coll Cardiol. 2017 Feb 7;69(5):570-591
pubmed: 28012615
Cardiovasc Interv Ther. 2018 Apr;33(2):99-108
pubmed: 27943219
Circ Cardiovasc Interv. 2015 Jun;8(6):e001715
pubmed: 26025217
J Am Coll Cardiol. 1994 Oct;24(4):1012-7
pubmed: 7930191
Eur Heart J. 1998 Aug;19(8):1214-23
pubmed: 9740343
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
Cardiovasc Revasc Med. 2015 Apr-May;16(3):167-71
pubmed: 25977227
Circ Res. 1964 Mar;14:250-9
pubmed: 14133952
N Engl J Med. 1994 Jun 23;330(25):1782-8
pubmed: 8190154
Circulation. 2000 Apr 18;101(15):1840-7
pubmed: 10769286
Circulation. 2000 May 23;101(20):2361-7
pubmed: 10821811
N Engl J Med. 2017 May 11;376(19):1824-1834
pubmed: 28317458
Int J Cardiovasc Imaging. 2017 Nov;33(11):1677-1684
pubmed: 28597125
J Am Coll Cardiol. 2012 Apr 10;59(15):1392-402
pubmed: 22154731

Auteurs

Akiko Matsuo (A)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan. Rudolf.Akiko@gmail.com.

Takeru Kasahara (T)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Makoto Ariyoshi (M)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Daisuke Irie (D)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Koji Isodono (K)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Yoshinori Tsubakimoto (Y)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Tomohiko Sakatani (T)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Keiji Inoue (K)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Hiroshi Fujita (H)

Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, 355-5 Haruobi-cho, Kamanzadorimarutamachi, Kamigyo-ku, Kyoto, 602-8026, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH